{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:56:06Z","timestamp":1792410966838,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071966"],"award-info":[{"award-number":["82071966"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771866"],"award-info":[{"award-number":["81771866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Photodynamic therapy (PDT) is a promising antitumor strategy with fewer adverse effects and higher selectivity than conventional therapies. Recently, a series of reports have suggested that PDT induced by Cerenkov radiation (CR) (CR-PDT) has deeper tissue penetration than traditional PDT; however, the strategy of coupling radionuclides with photosensitizers may cause severe side effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We designed tumor-targeting nanoparticles (<jats:sup>131<\/jats:sup>I-EM@ALA) by loading 5-aminolevulinic acid (ALA) into an <jats:sup>131<\/jats:sup>I-labeled exosome mimetic (EM) to achieve combined antitumor therapy. In addition to playing a radiotherapeutic role, <jats:sup>131<\/jats:sup>I served as an internal light source for the Cerenkov radiation (CR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The drug-loaded nanoparticles effectively targeted tumors as confirmed by confocal imaging, flow cytometry, and small animal fluorescence imaging. In vitro and in vivo experiments demonstrated that <jats:sup>131<\/jats:sup>I-EM@ALA produced a promising antitumor effect through the synergy of radiotherapy and CR-PDT. The nanoparticles killed tumor cells by inducing DNA damage and activating the lysosome-mitochondrial pathways. No obvious abnormalities in the hematology analyses, blood biochemistry, or histological examinations were observed during the treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We successfully engineered a nanocarrier coloaded with the radionuclide <jats:sup>131<\/jats:sup>I and a photosensitizer precursor for combined radiotherapy and PDT for the treatment of breast cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-022-01401-0","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T10:04:21Z","timestamp":1651053861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Minimizing adverse effects of Cerenkov radiation induced photodynamic therapy with transformable photosensitizer-loaded nanovesicles"],"prefix":"10.1186","volume":"20","author":[{"given":"Ruijie","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengpeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-2659","authenticated-orcid":false,"given":"Zairong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"1401_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis P, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250\u201381. https:\/\/doi.org\/10.3322\/caac.20114.","journal-title":"CA Cancer J Clin"},{"key":"1401_CR2","doi-asserted-by":"publisher","first-page":"22124","DOI":"10.1038\/s41598-020-79144-x","volume":"10","author":"VS Chelakkot","year":"2020","unstructured":"Chelakkot VS, et al. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1\u03b1-FECH axes. Sci Rep. 2020;10:22124\u201322124. https:\/\/doi.org\/10.1038\/s41598-020-79144-x.","journal-title":"Sci Rep"},{"key":"1401_CR3","doi-asserted-by":"publisher","first-page":"14971","DOI":"10.1021\/jacs.8b09374","volume":"140","author":"D Ni","year":"2018","unstructured":"Ni D, et al. Magnetic targeting of nanotheranostics enhances Cerenkov radiation-induced photodynamic therapy. J Am Chem Soc. 2018;140:14971\u20139. https:\/\/doi.org\/10.1021\/jacs.8b09374.","journal-title":"J Am Chem Soc"},{"key":"1401_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201704367","author":"S Goel","year":"2018","unstructured":"Goel S, et al. Activatable hybrid nanotheranostics for tetramodal imaging and synergistic photothermal\/photodynamic therapy. Adv Mater. 2018. https:\/\/doi.org\/10.1002\/adma.201704367.","journal-title":"Adv Mater"},{"key":"1401_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nnano.2015.17","volume":"10","author":"N Kotagiri","year":"2015","unstructured":"Kotagiri N, Sudlow GP, Akers WJ, Achilefu S. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat Nanotechnol. 2015;10:370\u20139. https:\/\/doi.org\/10.1038\/nnano.2015.17.","journal-title":"Nat Nanotechnol"},{"key":"1401_CR6","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1038\/ncomms10432","volume":"7","author":"X Ai","year":"2016","unstructured":"Ai X, et al. In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics. Nat Commun. 2016;7:10432. https:\/\/doi.org\/10.1038\/ncomms10432.","journal-title":"Nat Commun"},{"key":"1401_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/anie.201408472","volume":"54","author":"C Zhang","year":"2015","unstructured":"Zhang C, et al. Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence. Angew Chem. 2015;54:1770\u20134. https:\/\/doi.org\/10.1002\/anie.201408472.","journal-title":"Angew Chem"},{"key":"1401_CR8","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1021\/acsami.7b17902","volume":"10","author":"D Duan","year":"2018","unstructured":"Duan D, et al. Activating TiO(2) nanoparticles: gallium-68 serves as a high-yield photon emitter for Cerenkov-induced photodynamic therapy. ACS Appl Mater Interfaces. 2018;10:5278\u201386. https:\/\/doi.org\/10.1021\/acsami.7b17902.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1401_CR9","doi-asserted-by":"publisher","first-page":"26630","DOI":"10.1021\/acsami.6b10255","volume":"8","author":"A Kamkaew","year":"2016","unstructured":"Kamkaew A, et al. Cerenkov radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2016;8:26630\u20137. https:\/\/doi.org\/10.1021\/acsami.6b10255.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1401_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nnano.2016.301","volume":"12","author":"TM Shaffer","year":"2017","unstructured":"Shaffer TM, Pratt EC, Grimm J. Utilizing the power of Cerenkov light with nanotechnology. Nat Nanotechnol. 2017;12:106\u201317. https:\/\/doi.org\/10.1038\/nnano.2016.301.","journal-title":"Nat Nanotechnol"},{"key":"1401_CR11","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1039\/d0bm00778a","volume":"8","author":"P Cai","year":"2020","unstructured":"Cai P, et al. A chlorin-lipid nanovesicle nucleus drug for amplified therapeutic effects of lung cancer by internal radiotherapy combined with the Cerenkov radiation-induced photodynamic therapy. Biomater Sci. 2020;8:4841\u201351. https:\/\/doi.org\/10.1039\/d0bm00778a.","journal-title":"Biomater Sci"},{"key":"1401_CR12","doi-asserted-by":"publisher","first-page":"e1904894","DOI":"10.1002\/adma.201904894","volume":"31","author":"B Yu","year":"2019","unstructured":"Yu B, et al. A \u201cMissile-Detonation\u201d strategy to precisely supply and efficiently amplify Cerenkov radiation energy for cancer theranostics. Adv Mater. 2019;31:e1904894. https:\/\/doi.org\/10.1002\/adma.201904894.","journal-title":"Adv Mater"},{"key":"1401_CR13","doi-asserted-by":"publisher","first-page":"e2002054","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32:e2002054. https:\/\/doi.org\/10.1002\/adma.202002054.","journal-title":"Adv Mater"},{"key":"1401_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.addr.2012.06.011","volume":"65","author":"JG van den Boorn","year":"2013","unstructured":"van den Boorn JG, Dassler J, Coch C, Schlee M, Hartmann G. Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev. 2013;65:331\u20135. https:\/\/doi.org\/10.1016\/j.addr.2012.06.011.","journal-title":"Adv Drug Deliv Rev"},{"key":"1401_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jconrel.2011.11.021","volume":"161","author":"SM van Dommelen","year":"2012","unstructured":"van Dommelen SM, et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release. 2012;161:635\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2011.11.021.","journal-title":"J Control Release"},{"key":"1401_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.biomaterials.2016.06.024","volume":"102","author":"TR Lunavat","year":"2016","unstructured":"Lunavat TR, et al. RNAi delivery by exosome-mimetic nanovesicles\u2014implications for targeting c-Myc in cancer. Biomaterials. 2016;102:231\u20138. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.024.","journal-title":"Biomaterials"},{"key":"1401_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nmat4644","volume":"15","author":"R Molinaro","year":"2016","unstructured":"Molinaro R, et al. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater. 2016;15:1037\u201346. https:\/\/doi.org\/10.1038\/nmat4644.","journal-title":"Nat Mater"},{"key":"1401_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.7150\/thno.11852","volume":"5","author":"S Tan","year":"2015","unstructured":"Tan S, Wu T, Zhang D, Zhang Z. Cell or cell membrane-based drug delivery systems. Theranostics. 2015;5:863\u201381. https:\/\/doi.org\/10.7150\/thno.11852.","journal-title":"Theranostics"},{"key":"1401_CR19","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1021\/acsnano.8b02446","volume":"12","author":"YW Choo","year":"2018","unstructured":"Choo YW, et al. M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. ACS Nano. 2018;12:8977\u201393. https:\/\/doi.org\/10.1021\/acsnano.8b02446.","journal-title":"ACS Nano"},{"key":"1401_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12951-021-00827-2","volume":"19","author":"H Fang","year":"2021","unstructured":"Fang H, et al. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer. J Nanobiotechnol. 2021;19:81. https:\/\/doi.org\/10.1186\/s12951-021-00827-2.","journal-title":"J Nanobiotechnol"},{"key":"1401_CR21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1039\/d0bm00029a","volume":"8","author":"M Li","year":"2020","unstructured":"Li M, et al. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer. Biomater Sci. 2020;8:1802\u201314. https:\/\/doi.org\/10.1039\/d0bm00029a.","journal-title":"Biomater Sci"},{"key":"1401_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40820-020-0396-4","volume":"12","author":"H Fang","year":"2020","unstructured":"Fang H, et al. Ultra-sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL\/MRI\/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer. Nanomicro Lett. 2020;12:62. https:\/\/doi.org\/10.1007\/s40820-020-0396-4.","journal-title":"Nanomicro Lett"},{"key":"1401_CR23","unstructured":"The U.S. Food and drug administration. 5-aminolevulinic acid hydrochloride (5-ALA HCl). 2017. https:\/\/www.fda.gov\/media\/104876\/download."},{"issue":"Suppl 1","key":"1401_CR24","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/S0140-6736(15)60371-3","volume":"385","author":"YS Khaled","year":"2015","unstructured":"Khaled YS, Wright K, Melcher A, Jayne D. Anti-cancer effects of oncolytic viral therapy combined with photodynamic therapy in human pancreatic cancer cell lines. Lancet. 2015;385(Suppl 1):S56. https:\/\/doi.org\/10.1016\/S0140-6736(15)60371-3.","journal-title":"Lancet"},{"key":"1401_CR25","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.apsb.2021.03.017","volume":"11","author":"A Li","year":"2021","unstructured":"Li A, et al. Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation. Acta Pharm Sin B. 2021;11:1329\u201340. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.017.","journal-title":"Acta Pharm Sin B"},{"key":"1401_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jaad.2015.12.009","volume":"74","author":"J Kessels","year":"2016","unstructured":"Kessels J, Hendriks J, Nelemans P, Mosterd K, Kelleners-Smeets N. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): a retrospective case series and cohort study. J Am Acad Dermatol. 2016;74:899\u2013906. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.009.","journal-title":"J Am Acad Dermatol"},{"key":"1401_CR27","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.7150\/thno.49731","volume":"10","author":"X Xu","year":"2020","unstructured":"Xu X, et al. Broaden sources and reduce expenditure: tumor-specific transformable oxidative stress nanoamplifier enabling economized photodynamic therapy for reinforced oxidation therapy. Theranostics. 2020;10:10513\u201330. https:\/\/doi.org\/10.7150\/thno.49731.","journal-title":"Theranostics"},{"key":"1401_CR28","first-page":"163","volume":"2","author":"DL Thorek","year":"2012","unstructured":"Thorek DL, et al. Cerenkov imaging\u2014a new modality for molecular imaging. Am J Nucl Med Mol Imaging. 2012;2:163\u201373.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"1401_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.005","volume":"188","author":"H Cheng","year":"2019","unstructured":"Cheng H, et al. Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy. Biomaterials. 2019;188:1\u201311. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.10.005.","journal-title":"Biomaterials"},{"key":"1401_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biomaterials.2017.07.026","volume":"142","author":"SY Li","year":"2017","unstructured":"Li SY, et al. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials. 2017;142:149\u201361. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.07.026.","journal-title":"Biomaterials"},{"key":"1401_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endo-117-1-1","volume":"117","author":"JA Mol","year":"1985","unstructured":"Mol JA, Visser TJ. Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology. 1985;117:1\u20137. https:\/\/doi.org\/10.1210\/endo-117-1-1.","journal-title":"Endocrinology"},{"key":"1401_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.apsb.2018.12.004","volume":"9","author":"S Qi","year":"2019","unstructured":"Qi S, et al. Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway. Acta Pharm Sin B. 2019;9:279\u201393. https:\/\/doi.org\/10.1016\/j.apsb.2018.12.004.","journal-title":"Acta Pharm Sin B"},{"key":"1401_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15548627.2018.1515609","volume":"15","author":"WK Martins","year":"2019","unstructured":"Martins WK, et al. Parallel damage in mitochondria and lysosomes is an efficient way to photoinduce cell death. Autophagy. 2019;15:259\u201379. https:\/\/doi.org\/10.1080\/15548627.2018.1515609.","journal-title":"Autophagy"},{"key":"1401_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2967\/jnumed.115.164814","volume":"57","author":"U Eberlein","year":"2016","unstructured":"Eberlein U, et al. DNA damage in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy. J Nucl Med. 2016;57:173\u20139. https:\/\/doi.org\/10.2967\/jnumed.115.164814.","journal-title":"J Nucl Med"},{"key":"1401_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrgentox.2015.11.004","volume":"795","author":"J Zhang","year":"2016","unstructured":"Zhang J, et al. gamma-H2AX responds to DNA damage induced by long-term exposure to combined low-dose-rate neutron and gamma-ray radiation. Mutat Res Genet Toxicol Environ Mutagen. 2016;795:36\u201340. https:\/\/doi.org\/10.1016\/j.mrgentox.2015.11.004.","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"1401_CR36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2967\/jnumed.111.095943","volume":"53","author":"AG McCluskey","year":"2012","unstructured":"McCluskey AG, et al. Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine\/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter. J Nucl Med. 2012;53:1146\u201354. https:\/\/doi.org\/10.2967\/jnumed.111.095943.","journal-title":"J Nucl Med"},{"key":"1401_CR37","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ijc.30764","volume":"141","author":"M Gachechiladze","year":"2017","unstructured":"Gachechiladze M, Skarda J, Soltermann A, Joerger M. RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies. Int J Cancer. 2017;141:1286\u201394. https:\/\/doi.org\/10.1002\/ijc.30764.","journal-title":"Int J Cancer"},{"key":"1401_CR38","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","volume":"10","author":"T Yong","year":"2019","unstructured":"Yong T, et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun. 2019;10:3838. https:\/\/doi.org\/10.1038\/s41467-019-11718-4.","journal-title":"Nat Commun"},{"key":"1401_CR39","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","volume":"14","author":"RH Fang","year":"2014","unstructured":"Fang RH, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14:2181\u20138. https:\/\/doi.org\/10.1021\/nl500618u.","journal-title":"Nano Lett"},{"key":"1401_CR40","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1158\/0008-5472.CAN-04-0754","volume":"64","author":"WA Osta","year":"2004","unstructured":"Osta WA, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004;64:5818\u201324.","journal-title":"Cancer Res"},{"key":"1401_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201801198","author":"D Shao","year":"2018","unstructured":"Shao D, et al. Bioinspired diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein delivery. Adv Mater. 2018. https:\/\/doi.org\/10.1002\/adma.201801198.","journal-title":"Adv Mater"},{"key":"1401_CR42","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1002\/adma.201506086","volume":"28","author":"L Rao","year":"2016","unstructured":"Rao L, et al. Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging. Adv Mater. 2016;28:3460\u20136. https:\/\/doi.org\/10.1002\/adma.201506086.","journal-title":"Adv Mater"},{"key":"1401_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202107883","author":"Y Qu","year":"2021","unstructured":"Qu Y, et al. Cancer-cell-biomimetic nanoparticles for targeted therapy of multiple myeloma based on bone marrow homing. Adv Mater. 2021. https:\/\/doi.org\/10.1002\/adma.202107883.","journal-title":"Adv Mater"},{"key":"1401_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ceb.2015.04.013","volume":"35","author":"A Lo Cicero","year":"2015","unstructured":"Lo Cicero A, Stahl PD, Raposo G. Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr Opin Cell Biol. 2015;35:69\u201377. https:\/\/doi.org\/10.1016\/j.ceb.2015.04.013.","journal-title":"Curr Opin Cell Biol"},{"key":"1401_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ccell.2016.06.021","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, et al. Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell. 2016;30:243\u201356. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.021.","journal-title":"Cancer Cell"},{"key":"1401_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05696-x","author":"R Qian","year":"2022","unstructured":"Qian R, et al. Multi-antitumor therapy and synchronous imaging monitoring based on exosome. Eur J Nucl Med Mol Imaging. 2022. https:\/\/doi.org\/10.1007\/s00259-022-05696-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1401_CR47","doi-asserted-by":"publisher","first-page":"113623","DOI":"10.1016\/j.bios.2021.113623","volume":"194","author":"X Yu","year":"2021","unstructured":"Yu X, et al. Recent advances in cell membrane camouflage-based biosensing application. Biosens Bioelectron. 2021;194:113623. https:\/\/doi.org\/10.1016\/j.bios.2021.113623.","journal-title":"Biosens Bioelectron"},{"key":"1401_CR48","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1021\/acs.chemrev.0c00977","volume":"121","author":"Z Tang","year":"2021","unstructured":"Tang Z, Zhao P, Wang H, Liu Y, Bu W. Biomedicine meets fenton chemistry. Chem Rev. 2021;121:1981\u20132019. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00977.","journal-title":"Chem Rev"},{"key":"1401_CR49","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci M, Maksoudian C, Manshian BB, Soenen SJ. The Use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev. 2021;121:1746\u2013803. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00779.","journal-title":"Chem Rev"},{"key":"1401_CR50","doi-asserted-by":"publisher","first-page":"9806","DOI":"10.1039\/c5nr02470f","volume":"7","author":"H Ding","year":"2015","unstructured":"Ding H, et al. Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer. Nanoscale. 2015;7:9806\u201315. https:\/\/doi.org\/10.1039\/c5nr02470f.","journal-title":"Nanoscale"},{"key":"1401_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nnano.2013.254","volume":"8","author":"C-MJ Hu","year":"2013","unstructured":"Hu C-MJ, Fang RH, Luk BT, Zhang L. Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol. 2013;8:933\u20138. https:\/\/doi.org\/10.1038\/nnano.2013.254.","journal-title":"Nat Nanotechnol"},{"key":"1401_CR52","doi-asserted-by":"publisher","first-page":"9711","DOI":"10.1021\/acsnano.0c01350","volume":"14","author":"Y Deng","year":"2020","unstructured":"Deng Y, et al. 3-bromopyruvate-conjugated nanoplatform-induced pro-death autophagy for enhanced photodynamic therapy against hypoxic tumor. ACS Nano. 2020;14:9711\u201327. https:\/\/doi.org\/10.1021\/acsnano.0c01350.","journal-title":"ACS Nano"},{"key":"1401_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.redox.2018.10.011","volume":"20","author":"T Liu","year":"2019","unstructured":"Liu T, et al. Efficacy of 5-aminolevulinic acid-based photodynamic therapy against keloid compromised by downregulation of SIRT1-SIRT3-SOD2-mROS dependent autophagy pathway. Redox Biol. 2019;20:195\u2013203. https:\/\/doi.org\/10.1016\/j.redox.2018.10.011.","journal-title":"Redox Biol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01401-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01401-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01401-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T10:09:10Z","timestamp":1651054150000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01401-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1401"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01401-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental schemes were performed under the guidance and approved by the Institutional Animal Care and Use Committee of Tongji Medical College of Huazhong University of Science and Technology. Balb\/c mice (female, 5\u20136\u00a0weeks old) purchased from Weitong Lihua Laboratory Animal Center (Beijing, China), and maintained in a pathogen-free environment. Extensive efforts were made to ensure minimal suffering of the animals used during the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}